Mereo Biopharma Group Plc(MREO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MREO Mereo Biopharma Group Plc

休市中 05-03 16:00:00 EDT

3.26

+0.15

+4.82%

盘后3.18

-0.08-2.45%

17:45 EDT

最高3.35	最低3.14	成交量85.56万
今开3.16	昨收3.11	日振幅6.75%
总市值4.56亿	流通市值2.04亿	总股本1.40亿
成交额277.41万	换手率1.37%	流通股本6,251万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"MREO","market":"US","secType":"STK","nameCN":"Mereo Biopharma Group Plc","latestPrice":3.26,"timestamp":1714766400000,"preClose":3.11,"halted":0,"volume":855585,"hourTrading":{"tag":"盘后","latestPrice":3.18,"preClose":3.26,"latestTime":"17:45 EDT","volume":4086,"amount":13033.42,"timestamp":1714772741160},"delay":0,"floatShares":62514066,"shares":140024097,"eps":-0.223412,"marketStatus":"休市中","marketStatusCode":7,"change":0.15,"latestTime":"05-03 16:00:00 EDT","open":3.16,"high":3.35,"low":3.14,"amount":2774134.430172,"amplitude":0.067524,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.223412,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1714982400000},"adr":0,"listingDate":1556078400000,"adjPreClose":3.11,"adrRate":5,"postHourTrading":{"tag":"盘后","latestPrice":3.18,"preClose":3.26,"latestTime":"17:45 EDT","volume":4086,"amount":13033.42,"timestamp":1714772741160},"volumeRatio":0.8444059101387845},"requestUrl":"/m/hq/s/MREO","defaultTab":"news","newsList":[{"id":"2432184522","title":"Mereo Biopharma Group Plc盘中异动 大幅拉升5.14%报3.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432184522","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432184522?lang=zh_cn&edition=full","pubTime":"2024-05-04 01:42","pubTimestamp":1714758149,"startTime":"0","endTime":"0","summary":"北京时间2024年05月04日01时42分，Mereo Biopharma Group Plc股票出现波动，股价急速上涨5.14%。截至发稿，该股报3.27美元/股，成交量35.0394万股，换手率0.25%，振幅3.86%。Mereo Biopharma Group Plc股票所在的生物技术行业中，整体涨幅为0.25%。Mereo Biopharma Group Plc公司简介：Mereo BioPharma Group PLC 是一家总部位于英国的生物制药公司，专注于开发罕见疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405040142307a57fe69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405040142307a57fe69&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431932759","title":"Mereo Biopharma Group Plc盘中异动 早盘大幅拉升5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431932759","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431932759?lang=zh_cn&edition=full","pubTime":"2024-04-30 22:07","pubTimestamp":1714486073,"startTime":"0","endTime":"0","summary":"北京时间2024年04月30日22时07分，Mereo Biopharma Group Plc股票出现波动，股价大幅上涨5.07%。截至发稿，该股报2.90美元/股，成交量6.1649万股，换手率0.04%，振幅5.80%。Mereo Biopharma Group Plc股票所在的生物技术行业中，整体涨幅为0.62%。Mereo Biopharma Group Plc公司简介：Mereo BioPharma Group PLC 是一家总部位于英国的生物制药公司，专注于开发罕见疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404302207537a57c270&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404302207537a57c270&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430285216","title":"Mereo Biopharma Group Plc盘中异动 股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430285216","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430285216?lang=zh_cn&edition=full","pubTime":"2024-04-25 21:39","pubTimestamp":1714052375,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日21时39分，Mereo Biopharma Group Plc股票出现异动，股价大幅下挫5.04%。Mereo Biopharma Group Plc股票所在的生物技术行业中，整体跌幅为1.03%。其相关个股中，Processa Pharmaceuticals, Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Zura Bio Limited C/Wts 涨幅较大，Processa Pharmaceuticals, Inc.、Cyclacel Pharmaceuticals, Inc.、Cidara Therapeutics, Inc.较为活跃，换手率分别为935.26%、185.14%、7.24%，振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Processa Pharmaceuticals, Inc.、凯信远达，振幅分别为40.85%、25.31%、14.75%。Mereo Biopharma Group Plc公司简介：Mereo BioPharma Group PLC是一家多资产，临床阶段的生物制药公司。其肿瘤候选产品是etigilimab，用于实体瘤患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042521393679237625&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042521393679237625&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429080519","title":"Mereo Biopharma Group Plc盘中异动 快速拉升5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429080519","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429080519?lang=zh_cn&edition=full","pubTime":"2024-04-23 03:16","pubTimestamp":1713813388,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日03时16分，Mereo Biopharma Group Plc股票出现异动，股价急速拉升5.21%。Mereo Biopharma Group Plc股票所在的生物技术行业中，整体涨幅为1.82%。其相关个股中，Moolec Science Sa C/Wts 、Nkgen Biotech Inc C/Wts 31/05/2028、Moolec Science Sa涨幅较大，Moolec Science Sa、Phio Pharmaceuticals Corp.、Nkgen Biotech, Inc.较为活跃，换手率分别为202.72%、140.03%、101.32%，振幅较大的相关个股有Moolec Science Sa C/Wts 、Moolec Science Sa、Phio Pharmaceuticals Corp.，振幅分别为252.97%、82.14%、68.75%。Mereo Biopharma Group Plc公司简介：Mereo BioPharma Group PLC是一家多资产，临床阶段的生物制药公司。其肿瘤候选产品是etigilimab，用于实体瘤患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042303162987e8292b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042303162987e8292b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426292489","title":"Mereo Biopharma Group Plc盘中异动 大幅下跌5.34%报2.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426292489","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426292489?lang=zh_cn&edition=full","pubTime":"2024-04-12 03:50","pubTimestamp":1712865051,"startTime":"0","endTime":"0","summary":"北京时间2024年04月12日03时50分，Mereo Biopharma Group Plc股票出现异动，股价大幅下挫5.34%。Mereo Biopharma Group Plc股票所在的生物技术行业中，整体跌幅为0.40%。Mereo Biopharma Group Plc公司简介：Mereo BioPharma Group PLC是一家多资产，临床阶段的生物制药公司。其肿瘤候选产品是etigilimab，用于实体瘤患者。该信息摘要如下：Needham：重申Mereo BioPharma Group评级，由买入调整至买入评级, 目标价6.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404120350527a52322d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404120350527a52322d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426446494","title":"Mereo Biopharma Group Plc盘中异动 大幅下跌5.11%报2.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426446494","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426446494?lang=zh_cn&edition=full","pubTime":"2024-04-10 21:37","pubTimestamp":1712756274,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日21时37分，Mereo Biopharma Group Plc股票出现波动，股价快速跳水5.11%。Mereo Biopharma Group Plc股票所在的生物技术行业中，整体跌幅为1.27%。Mereo Biopharma Group Plc公司简介：Mereo BioPharma Group PLC是一家多资产，临床阶段的生物制药公司。其肿瘤候选产品是etigilimab，用于实体瘤患者。该信息摘要如下：Needham：重申Mereo BioPharma Group评级，由买入调整至买入评级, 目标价6.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041021375587e7f4b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041021375587e7f4b6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426115480","title":"Mereo Biopharma Group Plc盘中异动 股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426115480","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426115480?lang=zh_cn&edition=full","pubTime":"2024-04-09 22:40","pubTimestamp":1712673631,"startTime":"0","endTime":"0","summary":"北京时间2024年04月09日22时40分，Mereo Biopharma Group Plc股票出现波动，股价大幅下跌5.05%。Mereo Biopharma Group Plc股票所在的生物技术行业中，整体跌幅为0.14%。其相关个股中，Acrivon Therapeutics, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Mymd Pharmaceuticals, Inc.、Biophytis、Acrivon Therapeutics, Inc.较为活跃，换手率分别为427.59%、102.51%、65.46%，振幅较大的相关个股有Biophytis、Mymd Pharmaceuticals, Inc.、Jasper Therapeutics Inc C/Wts 24/09/2026 ，振幅分别为37.14%、29.18%、23.31%。Mereo Biopharma Group Plc公司简介：Mereo BioPharma Group PLC是一家多资产，临床阶段的生物制药公司。其肿瘤候选产品是etigilimab，用于实体瘤患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409224032861e4403&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409224032861e4403&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425341800","title":"Mereo Biopharma Group Plc盘中异动 股价大跌5.13%报3.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2425341800","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425341800?lang=zh_cn&edition=full","pubTime":"2024-04-05 02:33","pubTimestamp":1712255614,"startTime":"0","endTime":"0","summary":"北京时间2024年04月05日02时33分，Mereo Biopharma Group Plc股票出现异动，股价急速跳水5.13%。截至发稿，该股报3.24美元/股，成交量50.4277万股，换手率0.36%，振幅6.69%。Mereo Biopharma Group Plc股票所在的生物技术行业中，整体跌幅为0.73%。Mereo Biopharma Group Plc公司简介：Mereo BioPharma Group PLC是一家多资产，临床阶段的生物制药公司。其肿瘤候选产品是etigilimab，用于实体瘤患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404050233357a510894&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404050233357a510894&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422719437","title":"Mereo Biopharma Group Plc盘中异动 早盘股价大涨5.00%报3.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422719437","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422719437?lang=zh_cn&edition=full","pubTime":"2024-03-28 21:32","pubTimestamp":1711632724,"startTime":"0","endTime":"0","summary":"北京时间2024年03月28日21时32分，Mereo Biopharma Group Plc股票出现波动，股价快速上涨5.00%。截至发稿，该股报3.15美元/股，成交量7.515万股，换手率0.05%，振幅3.33%。Mereo Biopharma Group Plc股票所在的生物技术行业中，整体涨幅为0.13%。Mereo Biopharma Group Plc公司简介：Mereo BioPharma Group PLC是一家多资产，临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032821320587e7cbdf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032821320587e7cbdf&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419737903","title":"Mereo Biopharma Group Plc盘中异动 早盘股价大跌5.16%报2.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419737903","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419737903?lang=zh_cn&edition=full","pubTime":"2024-03-15 22:55","pubTimestamp":1710514552,"startTime":"0","endTime":"0","summary":"北京时间2024年03月15日22时55分，Mereo Biopharma Group Plc股票出现异动，股价大幅下挫5.16%。截至发稿，该股报2.98美元/股，成交量61.9507万股，换手率0.44%，振幅4.14%。Mereo Biopharma Group Plc股票所在的生物技术行业中，整体跌幅为0.25%。Mereo Biopharma Group Plc公司简介：Mereo BioPharma Group PLC是一家多资产，临床阶段的生物制药公司。其肿瘤候选产品是etigilimab，用于实体瘤患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403152255527a4d17be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403152255527a4d17be&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419319496","title":"Mereo Biopharma Group Plc盘中异动 股价大跌5.43%报3.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419319496","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419319496?lang=zh_cn&edition=full","pubTime":"2024-03-13 23:47","pubTimestamp":1710344875,"startTime":"0","endTime":"0","summary":"北京时间2024年03月13日23时47分，Mereo Biopharma Group Plc股票出现波动，股价大幅下挫5.43%。截至发稿，该股报3.31美元/股，成交量69.9778万股，换手率0.50%，振幅7.15%。Mereo Biopharma Group Plc股票所在的生物技术行业中，整体跌幅为0.43%。Mereo Biopharma Group Plc公司简介：Mereo BioPharma Group PLC是一家多资产，临床阶段的生物制药公司。其肿瘤候选产品是etigilimab，用于实体瘤患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240313234755791a1fe1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240313234755791a1fe1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416128538","title":"Mereo Biopharma Group Plc盘中异动 早盘股价大跌5.00%报3.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2416128538","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416128538?lang=zh_cn&edition=full","pubTime":"2024-03-04 23:20","pubTimestamp":1709565659,"startTime":"0","endTime":"0","summary":"北京时间2024年03月04日23时20分，Mereo Biopharma Group Plc股票出现波动，股价急速下挫5.00%。截至发稿，该股报3.77美元/股，成交量26.6956万股，换手率0.19%，振幅5.29%。Mereo Biopharma Group Plc股票所在的生物技术行业中，整体涨幅为0.02%。Mereo Biopharma Group Plc公司简介：Mereo BioPharma Group PLC是一家多资产，临床阶段的生物制药公司。其肿瘤候选产品是etigilimab，用于实体瘤患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403042320597a495372&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403042320597a495372&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414167804","title":"Mereo Biopharma Group Plc盘中异动 股价大涨5.20%报3.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2414167804","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2414167804?lang=zh_cn&edition=full","pubTime":"2024-02-27 23:57","pubTimestamp":1709049425,"startTime":"0","endTime":"0","summary":"北京时间2024年02月27日23时57分，Mereo Biopharma Group Plc股票出现波动，股价快速上涨5.20%。截至发稿，该股报3.84美元/股，成交量66.8685万股，换手率0.48%，振幅5.48%。Mereo Biopharma Group Plc股票所在的生物技术行业中，整体跌幅为0.37%。Mereo Biopharma Group Plc公司简介：Mereo BioPharma Group PLC是一家多资产，临床阶段的生物制药公司。其肿瘤候选产品是etigilimab，用于实体瘤患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402272357067a4756be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402272357067a4756be&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2413767458","title":"Mereo Biopharma Group Plc盘中异动 早盘快速上涨5.19%报3.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2413767458","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2413767458?lang=zh_cn&edition=full","pubTime":"2024-02-23 23:09","pubTimestamp":1708700979,"startTime":"0","endTime":"0","summary":"北京时间2024年02月23日23时09分，Mereo Biopharma Group Plc股票出现异动，股价大幅拉升5.19%。截至发稿，该股报3.65美元/股，成交量21.1114万股，换手率0.15%，振幅5.33%。Mereo Biopharma Group Plc股票所在的生物技术行业中，整体涨幅为0.83%。Mereo Biopharma Group Plc公司简介：Mereo BioPharma Group PLC是一家多资产，临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022323093987e72b18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022323093987e72b18&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2413486341","title":"Mereo Biopharma Group Plc盘中异动 急速跳水5.16%报3.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2413486341","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2413486341?lang=zh_cn&edition=full","pubTime":"2024-02-21 02:05","pubTimestamp":1708452325,"startTime":"0","endTime":"0","summary":"北京时间2024年02月21日02时05分，Mereo Biopharma Group Plc股票出现波动，股价大幅下挫5.16%。截至发稿，该股报3.52美元/股，成交量64.1453万股，换手率0.46%，振幅6.60%。Mereo Biopharma Group Plc股票所在的生物技术行业中，整体跌幅为0.91%。Mereo Biopharma Group Plc公司简介：Mereo BioPharma Group PLC是一家多资产，临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402210205267912ccbd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402210205267912ccbd&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2411688963","title":"Mereo Biopharma Group Plc盘中异动 早盘快速下挫5.40%报3.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2411688963","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2411688963?lang=zh_cn&edition=full","pubTime":"2024-02-13 22:31","pubTimestamp":1707834694,"startTime":"0","endTime":"0","summary":"北京时间2024年02月13日22时31分，Mereo Biopharma Group Plc股票出现波动，股价大幅下跌5.40%。Mereo Biopharma Group Plc股票所在的生物技术行业中，整体跌幅为0.66%。其相关个股中，Biodexa Pharmaceuticals Plc、Bioxcel Therapeutics Inc、Adial Pharmaceuticals Inc涨幅较大，Biodexa Pharmaceuticals Plc、Adial Pharmaceuticals Inc、Kintara Therapeutics Inc较为活跃，换手率分别为295.57%、81.29%、29.63%，振幅较大的相关个股有Biodexa Pharmaceuticals Plc、Biovie Inc、Rhythm Pharmaceuticals Inc，振幅分别为12.41%、12.28%、10.90%。Mereo Biopharma Group Plc公司简介：Mereo BioPharma Group PLC是一家多资产，临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021322313479113ba5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021322313479113ba5&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2410198723","title":"Mereo Biopharma Group Plc盘中异动 下午盘股价大涨5.04%报4.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2410198723","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2410198723?lang=zh_cn&edition=full","pubTime":"2024-02-09 02:45","pubTimestamp":1707417931,"startTime":"0","endTime":"0","summary":"北京时间2024年02月09日02时45分，Mereo Biopharma Group Plc股票出现波动，股价急速拉升5.04%。截至发稿，该股报4.07美元/股，成交量46.425万股，换手率0.33%，振幅5.43%。Mereo Biopharma Group Plc股票所在的生物技术行业中，整体涨幅为0.24%。Mereo Biopharma Group Plc公司简介：Mereo BioPharma Group PLC是一家多资产，临床阶段的生物制药公司。其肿瘤候选产品是etigilimab，用于实体瘤患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402090245317a42af8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402090245317a42af8a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2409640146","title":"Mereo Biopharma Group Plc盘中异动 早盘股价大涨6.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2409640146","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2409640146?lang=zh_cn&edition=full","pubTime":"2024-02-06 22:42","pubTimestamp":1707230558,"startTime":"0","endTime":"0","summary":"北京时间2024年02月06日22时42分，Mereo Biopharma Group Plc股票出现异动，股价急速拉升6.02%。Mereo Biopharma Group Plc股票所在的生物技术行业中，整体跌幅为0.12%。其相关个股中，Invivo Therapeutics Holding Corp、Tenax Therapeutics Inc、Jasper Therapeutics Inc C/Wts 24/09/2026 涨幅较大，Tenax Therapeutics Inc、Invivo Therapeutics Holding Corp、Revelation Biosciences Inc较为活跃，换手率分别为1206.22%、1099.23%、55.27%，振幅较大的相关个股有Invivo Therapeutics Holding Corp、Jasper Therapeutics Inc C/Wts 24/09/2026 、Tenax Therapeutics Inc，振幅分别为125.77%、58.70%、53.32%。Mereo Biopharma Group Plc公司简介：Mereo BioPharma Group PLC是一家多资产，临床阶段的生物制药公司。其肿瘤候选产品是etigilimab，用于实体瘤患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240206224238861d35a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240206224238861d35a5&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.mereobiopharma.com","stockEarnings":[{"period":"1week","weight":0.1898},{"period":"1month","weight":-0.044},{"period":"3month","weight":-0.1726},{"period":"6month","weight":0.5598},{"period":"1year","weight":1.5873},{"period":"ytd","weight":0.4113}],"compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":-0.0156},{"period":"3month","weight":0.0343},{"period":"6month","weight":0.1762},{"period":"1year","weight":0.262},{"period":"ytd","weight":0.0757}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Mereo BioPharma Group plc于2015年3月10日根据英格兰和威尔士法律注册成立.Mereo是一家生物制药公司，致力于创新疗法的开发和商业化，旨在改善罕见疾病患者的治疗效果。 Mereo的产品组合包括四个临床阶段候选产品，每个产品都来自大型制药公司。 Mereo正在开发用于治疗成骨不全症（“OI”）的BPS-804，用于治疗严重α-1抗胰蛋白酶缺乏症（“AATD”）的MPH-966，用于治疗慢性阻塞性肺疾病急性加重的BCT-197 疾病（“AECOPD”）和BGS-649用于治疗肥胖男性的低促性腺激素性性腺功能减退症（“HH”）。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.004235},{"month":2,"riseRate":0.6,"avgChangeRate":0.086714},{"month":3,"riseRate":0,"avgChangeRate":-0.201006},{"month":4,"riseRate":0.6,"avgChangeRate":0.139061},{"month":5,"riseRate":0.166667,"avgChangeRate":-0.122967},{"month":6,"riseRate":0.6,"avgChangeRate":0.498961},{"month":7,"riseRate":0.6,"avgChangeRate":-0.027644},{"month":8,"riseRate":0.8,"avgChangeRate":0.113615},{"month":9,"riseRate":0,"avgChangeRate":-0.157037},{"month":10,"riseRate":0.4,"avgChangeRate":0.10697},{"month":11,"riseRate":0.4,"avgChangeRate":-0.110062},{"month":12,"riseRate":0.6,"avgChangeRate":0.163438}],"exchange":"NASDAQ","name":"Mereo Biopharma Group Plc","nameEN":"Mereo Biopharma Group Plc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Mereo Biopharma Group Plc(MREO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Mereo Biopharma Group Plc(MREO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Mereo Biopharma Group Plc,MREO,Mereo Biopharma Group Plc股票,Mereo Biopharma Group Plc股票老虎,Mereo Biopharma Group Plc股票老虎国际,Mereo Biopharma Group Plc行情,Mereo Biopharma Group Plc股票行情,Mereo Biopharma Group Plc股价,Mereo Biopharma Group Plc股市,Mereo Biopharma Group Plc股票价格,Mereo Biopharma Group Plc股票交易,Mereo Biopharma Group Plc股票购买,Mereo Biopharma Group Plc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Mereo Biopharma Group Plc(MREO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Mereo Biopharma Group Plc(MREO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}